# NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $10,143,220

## Abstract

The Dale and Betty Bumpers Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), at the National Institutes of Health, was established to facilitate research in vaccine development and is dedicated to improving global human health through the rigorous pursuit of effective vaccines and treatments for human diseases. One of the key components of the VRC's mission involves the rapid advancement of promising candidates from the laboratory to the clinic. Meeting this mission necessitates the development and manufacturing of vaccines for toxicology, and Phase 1/11 clinical trials.

## Key facts

- **NIH application ID:** 10722425
- **Project number:** 75N91019D00024-P00001-759102200006-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** DAVID LINDSAY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $10,143,220
- **Award type:** —
- **Project period:** 2022-04-12 → 2027-07-17

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10722425

## Citation

> US National Institutes of Health, RePORTER application 10722425, NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines. (75N91019D00024-P00001-759102200006-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10722425. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*